Study details
Enrolling now
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
Virginia Commonwealth University
NCT IDNCT05548452ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
80
Study length
about 4.1 years
Ages
18+
Locations
2 sites in VA
What this study is about
Researchers are testing a treatment called Intestinal Microbiota Transplant (IMT) capsules to see if they can help with alcohol cravings and drinking. The trial will last for 1500 days, involving approximately 80 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Intestinal Microbiota Transplant (IMT) Capsules
- 2.Take Placebo Capsules
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in health related quality of live (HRQOL), Number of serious adverse events
Body systems
Psychiatry / Mental Health, Gastroenterology